MedTrace Logo

Childhood Cancer Predisposition Study (CCPS)

NCT04511806 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1050

Last updated 2025-10-29

No results posted yet for this study

Summary

The Childhood Cancer Predisposition Study (CCPS) is a multi-center, longitudinal, observational study that will collect clinical and biological data and specimens from children with a cancer predisposition syndromes (CPS) and their relatives.

The central hypothesis is that studying individuals at high risk for childhood cancer creates a unique opportunity for improving the understanding of carcinogenesis, tumor surveillance, early detection, and cancer prevention, which will collectively contribute to improving care and outcomes for pediatric patients with cancer and those with cancer predisposition syndromes (CPS).

Conditions

  • Pediatric Cancer

Interventions

OTHER

Registry

This prospective registry and biorepository will collect clinical data and specimens for research in childhood cancer predisposition.

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Christopher Porter, MD · Emory University

  • Anita Villani, MD · The Hospital for Sick Children

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-22
Primary Completion
2030-10-31
Completion
2030-10-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04511806 on ClinicalTrials.gov